Kinnate Biopharma Inc.
USD2.65
-0.01 (-0.38%)
CEO
Nima Farzan
IPO Date
2020-12-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.65
Prev. Close
$2.66
Day Low
$2.64
Day High
$2.67
52W Low
$1.04
52W High
$7.18
Market Cap
$0.12B
Volume
2.12M
| 60,751 |
| $5.63 |
| 5 Apr 2024 | Smaldone Alsup Laurie | director | D-Return | Disposed | 20,250 | $24.46 |
| 5 Apr 2024 | Smaldone Alsup Laurie | director | D-Return | Disposed | 20,250 | $8.38 |
| 5 Apr 2024 | Smaldone Alsup Laurie | director | D-Return | Disposed | 25,000 | $3.48 |
| 5 Apr 2024 | Epperly Melissa B, | director | D-Return | Disposed | 20,250 | $24.46 |
| 5 Apr 2024 | Epperly Melissa B, | director | D-Return | Disposed | 60,751 | $8.39 |
| 5 Apr 2024 | Epperly Melissa B, | director | D-Return | Disposed | 20,250 | $8.38 |
| 5 Apr 2024 | Epperly Melissa B, | director | D-Return | Disposed | 25,000 | $3.48 |
| 5 Apr 2024 | Farzan Nima | director, officer: CHIEF EXECUTIVE OFFICER | D-Return | Disposed | 275,000 | $35.38 |